[1]
2020. Rituximab in the Treatment of Refractory Myasthenia Gravis : Studying the Outcomes using MMT Score and Need for Plasmapheresis in Baghdad Teaching Hospital . Indian Journal of Forensic Medicine & Toxicology. 14, 2 (Apr. 2020), 1400–1405. DOI:https://doi.org/10.37506/ijfmt.v14i2.3108.